ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ANTX AN2 Therapeutics Inc

2.48
0.01 (0.40%)
After Hours
Last Updated: 07:31:28
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
AN2 Therapeutics Inc ANTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.01 0.40% 2.48 07:31:28
Open Price Low Price High Price Close Price Previous Close
2.48 2.43 2.5085 2.48 2.47
more quote information »

Recent News

Date Time Source Heading
29/3/202407:10BWAN2 Therapeutics Reports Fourth Quarter and Full Year 2023..
14/2/202409:11EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/2/202423:01EDGAR2Form 8-K - Current report
12/2/202422:45BWAN2 to Voluntarily Pause Enrollment in Phase 3 Part of Phase..
31/1/202408:10BWAN2 Therapeutics to Present at Oppenheimer Healthcare Life..
19/1/202410:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202409:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202409:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202411:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202410:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202410:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202408:45EDGAR2Form 144 - Report of proposed sale of securities
03/1/202408:36EDGAR2Form 144 - Report of proposed sale of securities
17/11/202310:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202308:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202308:10EDGAR2Form 8-K - Current report
10/11/202308:05BWAN2 Therapeutics Reports Third Quarter 2023 Financial..
06/11/202323:00BWAN2 Therapeutics to Present at Upcoming Investor Conferences
18/10/202322:00BWAN2 Therapeutics Signs License Agreement with the University..
11/10/202315:01BWAN2 Therapeutics to Present New Data for Epetraborole at..
04/10/202310:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202307:10EDGAR2Form 144 - Report of proposed sale of securities
30/9/202307:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/9/202306:11EDGAR2Form 144 - Report of proposed sale of securities
26/9/202321:00BWAN2 Therapeutics Signs Grant Agreement to Discover Novel,..
16/9/202307:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202322:00EDGAR2Form 8-K - Current report
13/9/202321:00BWAN2 Therapeutics commences Phase 3 Part of Phase 2/3..
09/9/202306:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/8/202306:14EDGAR2Form 144 - Report of proposed sale of securities
17/8/202306:50EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/8/202306:47EDGAR2Form 8-K - Current report
16/8/202312:42BWAN2 Therapeutics Announces Pricing of $70.0 Million..
11/8/202306:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202306:18EDGAR2Form 8-K - Current report
11/8/202306:10BWAN2 Therapeutics Reports Second Quarter 2023 Financial..
26/5/202306:10BWAN2 Therapeutics to Present at Jefferies Healthcare..
12/5/202306:10BWAN2 Therapeutics Reports First Quarter 2023 Financial..
01/5/202321:00BWAN2 Therapeutics to Present at JMP Securities Life Sciences..

Your Recent History

Delayed Upgrade Clock